Bridgefront Capital’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q1 | – | Sell |
-967
| Closed | -$389K | – | 868 |
|
2024
Q4 | $389K | Buy |
+967
| New | +$389K | 0.13% | 278 |
|
2022
Q3 | – | Sell |
-751
| Closed | -$212K | – | 471 |
|
2022
Q2 | $212K | Buy |
+751
| New | +$212K | 0.24% | 219 |
|
2021
Q4 | – | Sell |
-1,831
| Closed | -$332K | – | 460 |
|
2021
Q3 | $332K | Buy |
+1,831
| New | +$332K | 0.35% | 108 |
|